Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07778888) titled 'BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution Trial' on Aug. 18.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Bausch & Lomb Incorporated

Condition: Dry Eye Disease

Intervention: Drug: BL1107

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 2026

Target Sample Size: 20

To know more, visit https://clinicaltrials.gov/study/NCT07778888

Disclaimer: Curated by HT Syndication....